UNIVERSITY OF CALIFORNIA, DAVIS

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1905-01-01

Employees: 10K

Market Cap: -

Website: http://www.ucdavis.edu

Clinical Trials

Visual Interpretation of Neonatal Growth Charts

Completed

Conditions: Growth Acceleration
Growth Retardation

First Posted Date: 2015-03-31

Last Posted Date: 2017-06-21

Lead Sponsor: University of California, Davis

Target Recruit Count: 50

Registration Number: NCT02403739

Locations: 🇺🇸
UC Davis, Sacramento, California, United States

Dermal Suturing Only Versus Layered Cutaneous Closure

Not Applicable

Completed

Conditions: Wound Closure Techniques

Interventions: Procedure: Dermal Suturing Only Wound Closure
Procedure: Layered Cutaneous Wound Closure

First Posted Date: 2015-03-09

Last Posted Date: 2017-07-18

Lead Sponsor: University of California, Davis

Target Recruit Count: 50

Registration Number: NCT02383186

NSAIDS Versus Opioids in Acute SER II Ankle Fractures

Early Phase 1

Completed

Conditions: Ankle Fracture

Interventions: Drug: Acetaminophen/hydrocodone
Drug: Ibuprofen

First Posted Date: 2015-02-26

Last Posted Date: 2017-07-14

Lead Sponsor: University of California, Davis

Target Recruit Count: 1

Registration Number: NCT02373254

Locations: 🇺🇸
University of California Davis, Sacramento, California, United States

Impact of Individualized Radiotherapy Plan Review in Patients Receiving Adjuvant Radiotherapy for Breast Cancer

Completed

Conditions: Breast Cancer

First Posted Date: 2015-02-19

Last Posted Date: 2020-10-28

Lead Sponsor: University of California, Davis

Target Recruit Count: 72

Registration Number: NCT02366806

Locations: 🇺🇸
UC Davis Medical Center, Sacramento, California, United States

Pembrolizumab and Afatinib in Patients With Non-small Cell Lung Cancer With Resistance to Erlotinib

Phase 1

Completed

Conditions: Recurrent Non-Small Cell Lung Carcinoma
Stage IIIB Non-Small Cell Lung Cancer
Stage IV Non-Small Cell Lung Cancer
Stage IIIA Non-Small Cell Lung Cancer

Interventions: Drug: Afatinib Dimaleate
Biological: Pembrolizumab

First Posted Date: 2015-02-18

Last Posted Date: 2024-10-16

Lead Sponsor: Jonathan Riess

Target Recruit Count: 11

Registration Number: NCT02364609

Locations: 🇺🇸
University of California Davis Comprehensive Cancer Center, Sacramento, California, United States

NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse

Phase 2

Withdrawn

Conditions: Recurrent Adult Brain Neoplasm
Adult Brain Glioblastoma

Interventions: Procedure: Electric Field Therapy
Biological: Bevacizumab
Drug: Carmustine
Other: Quality-of-Life Assessment

First Posted Date: 2015-01-28

Last Posted Date: 2018-01-09

Lead Sponsor: University of California, Davis

Registration Number: NCT02348255

Locations: 🇺🇸
University of California Davis Comprehensive Cancer Center, Sacramento, California, United States
🇺🇸
Piedmont Hospital, Atlanta, Georgia, United States

Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate Cancer

Phase 1

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Drug: Enzalutamide
Drug: Metformin Hydrochloride

First Posted Date: 2015-01-15

Last Posted Date: 2024-05-08

Lead Sponsor: University of California, Davis

Target Recruit Count: 24

Registration Number: NCT02339168

Locations: 🇺🇸
University of California Davis Comprehensive Cancer Center, Sacramento, California, United States

Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis

Phase 1

Withdrawn

Conditions: Toxic Epidermal Necrolysis

Interventions: Drug: Clobetasol 0.05% ointment
Drug: Placebo

First Posted Date: 2014-12-18

Last Posted Date: 2019-08-09

Lead Sponsor: University of California, Davis

Registration Number: NCT02319616

Locations: 🇺🇸
University of California, Davis Department of Dermatology, Sacramento, California, United States

Evaluation of California's Armed and Prohibited Persons System

Not Applicable

Active, not recruiting

Conditions: Violence

Interventions: Behavioral: APPS intervention

First Posted Date: 2014-12-17

Last Posted Date: 2023-06-13

Lead Sponsor: University of California, Davis

Target Recruit Count: 20000

Registration Number: NCT02318732

Locations: 🇺🇸
UC Davis, Sacramento, California, United States

Novel Lung Functional Imaging for Personalized Radiotherapy

Not Applicable

Completed

Conditions: Lung Cancer

Interventions: Radiation: Ventilation image-guided radiotherapy

First Posted Date: 2014-12-04

Last Posted Date: 2022-11-10

Lead Sponsor: University of California, Davis

Target Recruit Count: 34

Registration Number: NCT02308709

Locations: 🇺🇸
University of California Davis Medical Center, Sacramento, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy